Stargardt disease: genes and variants
Explore variant evidence for Stargardt disease across 2 analyzed proteins (ABCA4, PRPH2). Linked ClinVar records include 45 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 15 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Stargardt disease
ABCA4: Retinal-specific phospholipid-transporting ATPase ABCA4
It flips retinal-derived lipid adducts across photoreceptor disc membranes so they can be cleared during the visual cycle. Biallelic loss-of-function variants cause Stargardt disease and can also produce cone-rod dystrophy or retinitis pigmentosa.
41 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in ABCA4 have source records linked to Stargardt disease. Association strength is not clinical gene validity.
PRPH2: Peripherin-2
It organizes and stabilizes the rim structure of photoreceptor outer-segment discs. Pathogenic variants cause a wide range of inherited retinal diseases including retinitis pigmentosa, pattern dystrophy, and macular dystrophy.
4 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in PRPH2 have source records linked to Stargardt disease. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): BEST1, RP2 and TULP1.
Where Stargardt disease variants cluster
- ABCA4 Cytoplasmic (positions 1–21): 4 of 40 ClinVar pathogenic / likely pathogenic variants, 10.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Stargardt disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PRPH2 C213Y | 213 | Lumenal | Pathogenic / likely pathogenic (★★) |
| PRPH2 C213S | 213 | Lumenal | Pathogenic / likely pathogenic (★★) |
| ABCA4 P640L | 640 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 L1784P | 1784 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 L1784R | 1784 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1843W | 1843 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 D2102E | 2102 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| ABCA4 E531G | 531 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 G2041D | 2041 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| ABCA4 M1T | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 A64V | 64 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 P143L | 143 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 S445R | 445 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 A801T | 801 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 A1219P | 1219 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1368C | 1368 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 L1583P | 1583 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 P1660L | 1660 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 P1776L | 1776 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 R1925I | 1925 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 R18Q | 18 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ABCA4 P32L | 32 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 M61I | 61 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 E207K | 207 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 Y340S | 340 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 L2035P | 2035 | ABC transporter 2 | Pathogenic / likely pathogenic (★★) |
| PRPH2 C250S | 250 | Lumenal | Pathogenic / likely pathogenic (★★) |
| ABCA4 R943W | 943 | ABC transporter 1 | Pathogenic / likely pathogenic (★★) |
| ABCA4 L1509P | 1509 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 Q1897H | 1897 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PRPH2 T228I | 228 | Lumenal | Pathogenic / likely pathogenic (★★) |
| ABCA4 M448V | 448 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 R785G | 785 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ABCA4 Q841P | 841 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 G1748R | 1748 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ABCA4 N14K | 14 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ABCA4 G818A | 818 | Extracellular | Pathogenic / likely pathogenic |
| ABCA4 H1838D | 1838 | Transmembrane | Pathogenic / likely pathogenic |
| ABCA4 M1V | 1 | Cytoplasmic | Pathogenic / likely pathogenic |
| ABCA4 C81S | 81 | Extracellular | Pathogenic / likely pathogenic |
| ABCA4 C230F | 230 | Extracellular | Pathogenic / likely pathogenic |
| ABCA4 D586E | 586 | Extracellular | Pathogenic / likely pathogenic |
| ABCA4 T1415P | 1415 | Extracellular | Pathogenic / likely pathogenic |
| ABCA4 R2030Q | 2030 | ABC transporter 2 | Pathogenic / likely pathogenic |
| ABCA4 G1961E | 1961 | ABC transporter 2 | Pathogenic / likely pathogenic |
Which prediction tools work for Stargardt disease
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 92 out of 100
- CADD: 90 out of 100
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 88 out of 100
- phyloP: 87 out of 100
- SIFT: 87 out of 100
- MetaSVM: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 42 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Severe early-childhood-onset retinal dystrophy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Stargardt disease variants (148 pathogenic / likely pathogenic).
- ABCA4-related retinopathy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Stargardt disease variants (60 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Stargardt disease variants (58 pathogenic / likely pathogenic).
- Age related macular degeneration also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Stargardt disease variants (41 pathogenic / likely pathogenic).
- Cone-rod dystrophy also has ClinVar records linked to ABCA4 variants; they fall mostly in different places as the Stargardt disease variants (29 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Stargardt disease variants (14 pathogenic / likely pathogenic).
- Patterned dystrophy of the retinal pigment epithelium also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Stargardt disease variants (11 pathogenic / likely pathogenic).
- Fundus albipunctatus also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Stargardt disease variants (3 pathogenic / likely pathogenic).
- Patterned macular dystrophy also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Stargardt disease variants (3 pathogenic / likely pathogenic).
- Vitelliform macular dystrophy also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Stargardt disease variants (3 pathogenic / likely pathogenic).
Diseases related to Stargardt disease
- Retinitis pigmentosa, also linked to ABCA4 and PRPH2
- Cone-rod dystrophy, also linked to ABCA4 and PRPH2
- Retinal disorder, also linked to ABCA4 and PRPH2
- Leber congenital amaurosis, also linked to ABCA4
- Severe early-childhood-onset retinal dystrophy, also linked to ABCA4
- ABCA4-related retinopathy, also linked to ABCA4
- Age related macular degeneration, also linked to ABCA4
- Vitelliform macular dystrophy, also linked to PRPH2
- Patterned dystrophy of the retinal pigment epithelium, also linked to PRPH2
- Optic atrophy, also linked to ABCA4
- Stationary night blindness, also linked to ABCA4
- Fundus albipunctatus, also linked to PRPH2
Frequently asked questions
Which genes have records linked to Stargardt disease?
This view contains 2 analyzed proteins: ABCA4, PRPH2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 45 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 15 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 97 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center